Sung Kwang Son

This inventor holds 16 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 32 EPO patents. Top assignees: Cj Cheiljedang Corporation, Arkema France. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung Kwang Son. Retrieved from https://idiyas.com/inventor/sung-kwang-son

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 32 (Patent Applications = 31)

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 24(Granted Patents)

Location History:

Gyeonggi-do, KR (2021)
Seoul, KR (2012 - 2022)

Company Filing History:

16 out of 972

Cj Cheiljedang Corporation

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723242 - NOVEL GLUTAMINE-HYDROLYZING GMP SYNTHASE VARIANT AND METHOD FOR PRODUCING PURINE NUCLEOTIDE BY USING SAME (2026-09-01),

2. 11524981 - L-tryptophan-exporting protein variant and method for producing L-tryptophan using the same (2022-12-13),

3. 10995378 - L-tryptophan exporter and method of producing L-tryptophan using the same (2021-05-04),

4. 10815509 - Microorganism producing O-acetyl homoserine and the method of producing O-acetyl homoserine using the same (2020-10-27),

5. 10501763 - Microorganism producing O-acetyl-homoserine and method for producing O-acetylhomoserine using the same (2019-12-10),

6. 10465217 - Microorganism producing O-acetyl homoserine and the method of producing O-acetyl homoserine using the same (2019-11-05),

7. 10378031 - O-acetylhomoserine sulfhydrylase variant and method for producing L-methionine using same (2019-08-13),

8. 9534240 - Recombinant microorganism producing quinolinic acid and a method for producing quinolinic acid using the same (2017-01-03),

9. 9365877 - Preparation of process of L-methionine (2016-06-14),

10. 9297030 - Method for the preparation of nicotinic acid (2016-03-29),

11. 9290743 - L-aspartate oxidase variant and a method for producing quinolinate or nicotinic acid using the same (2016-03-22),

12. 9127257 - Modified polypeptide having homoserine acetyltransferase activity and microorganism expressing the same (2015-09-08),

13. 9080155 - O-acetylhomoserine sulfhydrylase or mutant protein thereof, and method for converting to methionine using the same (2015-07-14),

14. 9024063 - Method for increasing methionine productivity using a mixture of methyl mercaptan and dimethyl sulfide (2015-05-05),

15. 8609396 - Microorganism producing O-acetyl-homoserine and the method of producing O-acetyl-homoserine using the microorganism (2013-12-17),

Title: The Innovative Journey of Sung Kwang Son

Introduction

Sung Kwang Son, an accomplished inventor based in Gyeonggi-do, South Korea, has made significant contributions to the field of biochemistry and microbial production. With a remarkable portfolio of 15 patents, his work primarily focuses on the development of protein variants that enhance the production of essential amino acids, such as L-tryptophan.

Latest Patents

Among his latest innovations are two noteworthy patents:

1. "L-tryptophan-exporting protein variant and method for producing L-tryptophan using the same." This patent emphasizes a protein variant designed to export tryptophan efficiently. It outlines a method involving a microorganism expressing the protein variant for the effective production of L-tryptophan.

2. "L-tryptophan exporter and method of producing L-tryptophan using the same." This disclosure focuses on a genetically modified microorganism that produces L-tryptophan. It is modified to express a protein with a specific amino acid sequence, facilitating enhanced production methods utilizing this microorganism.

Career Highlights

Throughout his career, Sung Kwang Son has collaborated with prominent companies, including CJ Cheiljedang Corporation and Arkema France. His work has been pivotal in advancing biotechnological applications, particularly in the optimization of amino acid production, which is crucial for various industrial applications.

Collaborations

Sung Kwang Son has worked alongside talented coworkers such as So Young Kim and Yong Uk Shin. These collaborations have helped bridge expertise in microbiology and biochemistry, paving the way for front-line advancements in the fields of synthetic biology and metabolic engineering.

Conclusion

Sung Kwang Son stands out as a leading inventor whose innovative breakthroughs in protein engineering and microbial production significantly impact the biosynthesis of vital compounds. His ongoing contributions will continue to shape the landscape of biotechnology, making him a notable figure in the field.

Profile summary based on public USPTO records.